Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
X
Scientific presentation

Clonal evolution underlying clinical responses and relapses in subjects with IDH1-mutated AML treated with ivosidenib monotherapy or ivosidenib + azacitidine


Dylan Marchione, PhD
Description

At this year’s World CB & CDx conference held in Boston, Dylan Marchione, PhD, of Servier Pharmaceuticals presented data supporting the use of the Tapestri Platform in clinical development to elucidate clonal evolution patterns in patients with IDH1-mutated AML treated with combination therapy, TIBSOVO + azacitidine, as compared to monotherapy.



VIEW


Scientific presentation
Leverage Single-cell Multi-parametric Datasets to Advance Heme Oncology Pipelines
Azad Gucwa, PhD
14th World Clinical Biomarkers & Companion Diagnostics Summit (2024)
Scientific presentation
DKFZ Seminar: Somatic epimutations enable single-cell lineage tracing in native hematopoiesis across the murine and human lifespan
Martina Braun
(2024)
Scientific presentation
DKFZ Seminar: Functional phenotyping of genomic variants using multiomic scDNA-scRNA-seq
Dominik Lindenhofer
(2024)
Scientific presentation
DKFZ Seminar: Clonal evolution in NPM1c AML
Wout Megchelenbrink
(2024)
REQUEST QUOTE